AGA GUIDELINES Bundle (free trial)

Elastography in the Evaluation of Liver Fibrosis

AGA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512410

Contents of this Issue

Navigation

Page 2 of 5

Management Diagnosis ➤ In patients with chronic hepatitis C, AGA recommends VCTE, if available, rather than other nonproprietary, noninvasive serum tests (APRI, FIB-4) to detect cirrhosis. (Strong recommendation, moderate quality evidence) ➤ In patients with chronic hepatitis C, AGA suggests a VCTE cutoff of 12.5 kPa to detect cirrhosis. (Conditional recommendation, low-quality evidence) ➤ In noncirrhotic patients with HCV who have achieved a sustained viral response (SVR) after antiviral therapy, AGA suggests a post-treatment VCTE cutoff of 9.5 kPa to rule out advanced liver fibrosis. (Conditional recommendation, very-low quality evidence) Comment: Noncirrhotic patients with VCTE <9.5 kPa who place a low value on the inconvenience and risks of continued laboratory and fibrosis testing, and a high value on avoiding the small risk of developing HCC, may reasonably select to continue specialty care rather than being discharged from the specialty clinic. ➤ In patients with chronic hepatitis B, AGA suggests VCTE rather than other nonproprietary noninvasive serum tests (ie, APRI and FIB-4) to detect cirrhosis. (Conditional recommendation, low-quality evidence) ➤ In patients with chronic hepatitis B, AGA suggests a VCTE cutoff of 11.0 kPa to detect cirrhosis. (Conditional recommendation, low-quality evidence) ➤ AGA makes no recommendation regarding the role of VCTE in the diagnosis of cirrhosis in adults with NAFLD. (No recommendation—knowledge gap) ➤ In patients with chronic alcoholic liver disease, AGA suggests a VCTE cutoff of 12.5 kPa to detect cirrhosis. (Conditional recommendation, low-quality evidence) ➤ In patients with suspected compensated cirrhosis, AGA suggests a VCTE cutoff of 19.5 kPa to assess the need for esophagogastroduodenoscopy to identify high risk esophageal varices. (Conditional recommendation, low- quality evidence) Comment: Patients, particularly those at higher risk, with VCTE <19.5 kPa who place a low value on the inconvenience and risks of endoscopy, and a high value on avoiding the small risk of acute variceal hemorrhage associated with VCTE values of <19.5 kPa, may reasonably select to undergo screening endoscopy.

Articles in this issue

Archives of this issue

view archives of AGA GUIDELINES Bundle (free trial) - Elastography in the Evaluation of Liver Fibrosis